Venator Materials Adds Even More Underwriters to IPO

Industrials

Published: July 14, 2017 8:15 am

Last Updated: January 12, 2020 10:09 am

Venator Materials has registered an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). No pricing details were mentioned in the filing, but the offering is valued up to $100 million, although this number tends to be just a placeholder.

After the completion of this offering, Huntsman Corporation will continue to control a majority of the voting power of the ordinary shares. As a result, Venator will be a “controlled company.” It intends to list its shares on the New York Stock Exchange under the symbol VNTR.

The sole underwriter in the original filing was Merrill Lynch, but with this amendment a slew of underwriters jumped on board. Those added since then are Citigroup, Goldman Sachs, JPMorgan, Barclays, Deutsche Bank, UBS Investment Bank, RBC Capital Markets, Moelis, HSBC, Nomura, SunTrust Robinson Humphrey, Academy Securities and Commerzbank. With this addition of underwriters there could be a big influx of funding to come in the next updated filing.

This leading global manufacturer and marketer of chemical products intends to improve the quality of life for downstream consumers and promote a sustainable future. Its products comprise a broad range of pigments and additives that bring color and vibrancy to buildings, protect and extend product life and reduce energy consumption.

The company markets its products globally to a diversified group of industrial customers through two segments: Titanium Dioxide, which consists of its TiO2 business, and Performance Additives, which consists of its functional additives, color pigments, timber treatment and water treatment businesses.

Venator is a leading global producer in many of these key product lines, including TiO2, color pigments and functional additives, a leading North American producer of timber treatment products and a leading European producer of water treatment products. It operates 27 facilities, employs approximately 4,500 associates worldwide and sells its products in more than 110 countries.

For the 12 months ended March 31, 2017, it had total pro forma revenues of $2,136 million.

The company will not receive any proceeds from this offering.

Travel Cards Are Getting Too Good To Ignore

Credit card companies are pulling out all the stops, with the issuers are offering insane travel rewards and perks.

We’re talking huge sign-up bonuses, points on every purchase, and benefits like lounge access, travel credits, and free hotel nights. For travelers, these rewards can add up to thousands of dollars in flights, upgrades, and luxury experiences every year.

It’s like getting paid to travel — and it’s available to qualified borrowers who know where to look.

We’ve rounded up some of the best travel credit cards on the market. Click here to see the list. Don’t miss these offers — they won’t be this good forever.